Immunovant, Inc.IMVTNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank14
3Y CAGR-69.8%
5Y CAGR-66.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-69.8%/yr
Annual compound
5Y CAGR
-66.7%/yr
Recent deceleration
Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
6 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00 | -38.0% |
| 2024 | 0.00 | -93.4% |
| 2023 | 0.00 | -33.1% |
| 2022 | 0.01 | -42.4% |
| 2021 | 0.01 | -74.3% |
| 2020 | 0.03 | -99.7% |
| 2019 | 12.22 | - |
| 2018 | 0.00 | - |